The effect of goal-directed therapy on mortality in patients with sepsis - earlier is better: A meta-analysis of randomized controlled trials

Critical Care

Volumn 18, Issue 5, 2014, Pages

  Gu, Wan Jie ^a   Wang, Fei ^b   Bakker, Jan ^c   Tang, Lu ^b   Liu, Jing Chen ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b JINAN MILITARY GENERAL HOSPITAL   (China)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE;

ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; COMPARATIVE EFFECTIVENESS; DRUG USE; EVIDENCE BASED MEDICINE; GOAL DIRECTED THERAPY; HUMAN; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESUSCITATION; RISK FACTOR; SEPSIS; ADULT; MOTIVATION;

ADULT; GOALS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESUSCITATION; SEPSIS;

EID: 84988693688     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-014-0570-5     Document Type: Article

References (31)

1. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R, Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013, 41:580-637.
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310.
3. Annane D, Bellissant E, Cavaillon JM: Septic shock. Lancet 2005, 365:63-78.
4. Centers for Disease Control and Prevention (CDC): Current trends: increase in National Hospital Discharge Survey rates for septicemia-United States, 1979-1987. MMWR Morb Mortal Wkly Rep 1990, 39:31-34.
5. Cecconi M, Corredor C, Arulkumaran N, Abuella G, Ball J, Grounds RM, Hamilton M, Rhodes A: Clinical review: goal-directed therapy -What is the evidence in surgical patients? The effect on different risk groups. Crit Care 2013, 17:209.
6. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377.
7. ProCESS Investigators: A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014, 370:1683-1693.
8. Higgins JPT, Green S (Eds): Cochrane Handbook for Systematic Reviews of Interventions (Version 5.1.0) [updated March 2011]. The Cochrane Collaboration; 2011. Available from www.cochrane-handbook.org.
9. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009, 339:b2535.
10. Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, Cochrane Bias Methods Group, Cochrane Statistical Methods Group: The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011, 343:d5928.
11. Higgins JPT, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
12. Higgins JPT, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
13. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
14. Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
15. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ, GRADE Working Group: GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008, 336:924-926.
16. Tuchschmidt J, Fried J, Astiz M, Rackow E: Elevation of cardiac output and oxygen delivery improves outcome in septic shock. Chest 1992, 102:216-220.
17. Yu M, Levy MM, Smith P, Takiguchi SA, Miyasaki A, Myers SA: Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: a prospective, randomized, controlled study. Crit Care Med 1993, 21:830-838.
18. Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ, Watson D: Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994, 330:1717-1722.
19. Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, Fumagalli R: SvO2 Collaborative Group: A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 1995, 333:1025-1032.
20. Yu M, Burchell S, Hasaniya NW, Takanishi DM, Myers SA, Takiguchi SA: Relationship of mortality to increasing oxygen delivery in patients =50 years of age: a prospective, randomized trial. Crit Care Med 1998, 26:1011-1019.
21. Alía I, Esteban A, Gordo F, Lorente JA, Diaz C, Rodriguez JA, Frutos F: A randomized and controlled trial of the effect of treatment aimed at maximizing oxygen delivery in patients with severe sepsis or septic shock. Chest 1999, 115:453-461.
22. Lin SM, Huang CD, Lin HC, Liu CY, Wang CH, Kuo HP: A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: a randomized controlled trial. Shock 2006, 26:551-557.
23. Wang XZ, Lü CJ, Gao FQ, Li XH, Yan WF, Ning FY: [Efficacy of goal-directed therapy in the treatment of septic shock] [Article in Chinese]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2006, 18:661-664.
24. Chen ZQ, Jin YH, Chen H, Fu WJ, Yang H, Wang RT: [Early goal-directed therapy lowers the incidence, severity and mortality of multiple organ dysfunction syndrome] [Article in Chinese]. Nan Fang Yi Ke Da Xue Xue Bao 2007, 27:1892-1895.
25. He ZY, Gao Y, Wang XR, Hang YN: [Clinical evaluation of execution of early goal directed therapy in septic shock] [Article in Chinese]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2007, 19:14-16.
26. Early Goal-Directed Therapy Collaborative Group of Zhejiang Province: [The effect of early goal-directed therapy on treatment of critical patients with severe sepsis/septic shock: a multi-center, prospective, randomized, controlled study] [Article in Chinese]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2010, 22:331-334.
27. Wira CR, Dodge K, Sather J, Dziura J: Meta-analysis of protocolized goal-directed hemodynamic optimization for the management of severe sepsis and septic shock in the emergency department. West J Emerg Med 2014, 15:51-59.
28. Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA, Emergency Medicine Shock Research Network (EMShockNet) Investigators: Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA 2010, 303:739-746.
29. Jansen TC, van Bommel J, Schoonderbeek FJ, Sleeswijk Visser SJ, van der Klooster JM, Lima AP, Willemsen SP, Bakker J, LACTATE study group: Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med 2010, 182:752-761.
30. Legrand M, Dupuis C, Simon C, Gayat E, Mateo J, Lukaszewicz AC, Payen D: Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: a retrospective observational study. Crit Care 2013, 17:R278.
31. The ProCESS/ARISE/ProMISe Methodology Writing Committee: Harmonizing international trials of early goal-directed resuscitation for severe sepsis and septic shock: methodology of ProCESS, ARISE, and ProMISe. Intensive Care Med 2013, 39:1760-1775.